These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32720296)

  • 1. The CECMED Office of Innovation: A Core Initiative to Bolster Novel Pharmaceutical Products-The Cuban Approach.
    Romeu B; Perez Cristiá R
    Ther Innov Regul Sci; 2021 Jan; 55(1):163-169. PubMed ID: 32720296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Regulatory Sciences from the Perspective of the Cuban Medicines Regulatory Agency: The Impact of COVID-19 in Promoting Innovation, Cooperation and Scientific Thinking.
    Romeu B; Rodríguez Y; Bendiner S
    Ther Innov Regul Sci; 2021 Sep; 55(5):1014-1018. PubMed ID: 33939173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cuba's National Regulatory Authority & COVID-19: Olga Lidia Jacobo-Casanueva MS Director, Center for State Control of Medicines and Medical Devices (CECMED).
    Aguilar-Guerra TL; Fajardo-Díaz EM; Gorry C
    MEDICC Rev; 2021; 23(3-4):9-14. PubMed ID: 34516531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From molecule to market access: drug regulatory science as an upcoming discipline.
    Gispen-de Wied CC; Leufkens HGM
    Eur J Pharmacol; 2013 Nov; 719(1-3):9-15. PubMed ID: 23891846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulatory framework for similar biotherapeutic products in Cuba.
    Hechavarría Núñez Y; Pérez Massipe RO; Orta Hernández SD; Muñoz LM; Jacobo Casanueva OL; Pérez Rodríguez V; Domínguez Morales RB; Pérez Cristiá RB
    Biologicals; 2011 Sep; 39(5):317-20. PubMed ID: 21930393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strengthening Health Products Regulatory Systems to Enhance Access to Quality Health Products in the Asia-Pacific.
    Lim JCW
    Ther Innov Regul Sci; 2018 Nov; 52(6):751-754. PubMed ID: 29714589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Japanese Regulatory Frameworks for Post-Marketing Management of Pharmaceutical Products.
    Takamura K; Tachibana K; Kusakabe T; Nakai K; Tsutsumi Y; Kondoh M
    Pharm Res; 2020 Jun; 37(7):122. PubMed ID: 32514811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality by design (QbD) approach in marketing authorization procedures of Non-Biological Complex Drugs: A critical evaluation.
    Zagalo DM; Sousa J; Simões S
    Eur J Pharm Biopharm; 2022 Sep; 178():1-24. PubMed ID: 35908664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Worldwide Overview of Regulatory Frameworks for Tissue-Based Products.
    Oberweis CV; Marchal JA; López-Ruiz E; Gálvez-Martín P
    Tissue Eng Part B Rev; 2020 Apr; 26(2):181-196. PubMed ID: 31910099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Innovation Office of the Paul-Ehrlich-Institut. Regulatory support during the scientific development of ATMP].
    Ziegele B; Dahl L; Müller AT
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):857-66. PubMed ID: 21698540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosimilars in psoriasis: Clinical practice and regulatory perspectives in Latin America.
    de la Cruz C; de Carvalho AV; Dorantes GL; Londoño Garcia AM; Gonzalez C; Maskin M; Podoswa N; Redfern JS; Valenzuela F; van der Walt J; Romiti R
    J Dermatol; 2017 Jan; 44(1):3-12. PubMed ID: 27461455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthy bi-regional connection: The EU-LAC Health initiative has promoted equitable and collaborative health research and innovation.
    Corral T; de Román M; Gómez-Núñez AJ; Mourenza B; Quental C; Splett-Rudolf S; de Andrés R
    Health Res Policy Syst; 2018 Nov; 16(1):114. PubMed ID: 30470236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical Innovation in Latin America and the Caribbean.
    Vargas V; Darrow J
    J Law Med Ethics; 2023; 51(S1):148-162. PubMed ID: 38156355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Health-Promoting Schools Regional Initiative of the Americas].
    Ippolito-Shepherd J; Cerqueira MT; Ortega DP
    Promot Educ; 2005; 12(3-4):220-9, 180. PubMed ID: 16739516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing pharmaceutical quality: An overview of science and research in the U.S. FDA's Office of Pharmaceutical Quality.
    Fisher AC; Lee SL; Harris DP; Buhse L; Kozlowski S; Yu L; Kopcha M; Woodcock J
    Int J Pharm; 2016 Dec; 515(1-2):390-402. PubMed ID: 27773853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UK medicines regulation: responding to current challenges.
    Richards N; Hudson I
    Br J Clin Pharmacol; 2016 Dec; 82(6):1471-1476. PubMed ID: 27580254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing patient access to pharmaceuticals in the UK and US.
    Cohen J; Cairns C; Paquette C; Faden L
    Appl Health Econ Health Policy; 2006; 5(3):177-87. PubMed ID: 17132032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Science at the Service of Public Health: Rafael Pérez Cristiá MD PhD Center for State Control of Medicines and Medical Devices.
    Gorry C
    MEDICC Rev; 2018 Jan; 20(1):8. PubMed ID: 34229415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.